Immunic Share Price Today
(NASDAQ: IMUX)

Name: Immunic Share Price Today (NASDAQ: IMUX) - Immunic Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Immunic share price is $1.17 & ₹101.75 as on 6 Mar 2025, 2.30 'hrs' IST

$1.17

Market is closed - opens 8 PM, 06 Mar 2025

View live Immunic share price in Dollar and Rupees. Guide to invest in Immunic stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunic, along with analyst recommendations, forecasts, and comprehensive financials.

Immunic share price movements

Today's Low: $1.15
Today's High: $1.20
$1.17
1.71%
Downside
Day's Volatility :3.77%
Upside
2.09%
52 Weeks Low: $0.92
52 Weeks High: $2.11
$1.17
21.33%
Downside
52 Weeks Volatility :56.38%
Upside
44.55%

Immunic (IMUX) Returns

Period	Immunic Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-4.1%	2.1%	0.0%
6 Months	-14.6%	-4.1%	0.0%
1 Year	-20.41%	2.2%	0.0%
3 Years	-88.54%	11.8%	-11.6%

Immunic (IMUX) Key Statistics

in dollars & INR

Previous Close	$1.17
Open	$1.17
Today's High	$1.195
Today's Low	$1.15
Market Capitalization	$104.5M
Today's Volume	$44.7K
52 Week High	$2.11
52 Week Low	$0.9204
Revenue TTM	$0.0
EBITDA	$-95.7M
Earnings Per Share (EPS)	$-1.23
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-216.24%

How to invest in Immunic Stock (IMUX) from India?

It is very easy for Indian residents to invest directly in Immunic from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunic stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunic or IMUX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunic or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunic shares which would translate to 0.743 fractional shares of Immunic as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immunic, in just a few clicks!

Returns in Immunic (IMUX) for Indian investors in Rupees

The Immunic stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Immunic investment value today

Current value as on today

₹84,555

Returns

₹15,445

(-15.45%)

Returns from Immunic Stock

₹20,408 (-20.41%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Immunic (IMUX)

17%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Immunic Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immunic

Bvf Inc
9.88%
Avidity Partners Management LP
8.84%
Soleus Capital Management, L.P.
8.10%
RTW INVESTMENTS, LLC
5.07%
Vanguard Group Inc
4.36%
HHG PLC
2.99%

Analyst Recommendation on Immunic

Buy

81%Buy

18%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Immunic(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Immunic Stock (IMUX)

What analysts predicted

Upside of 1025.36%

Target:

$13.17

Current:

$1.17

Insights on Immunic Stock (Ticker Symbol: IMUX)

Price Movement
In the last 1 month, IMUX stock has moved up by 18.8%
IMUX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 84.3%
IMUX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 136.7%

Immunic Technicals Summary

Sell

Neutral

Buy

Immunic is currently in a neutral trading position according to technical analysis indicators.

Immunic (IMUX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunic Inc	21.19%	-14.6%	-20.41%	-88.54%	-86.1%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunic Inc	NA	NA	NA	-0.96	-2.16	-0.91	NA	0.46
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunic Inc	Buy	$104.5M	-86.1%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Immunic

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Organization	Immunic
Employees	85
CEO	Dr. Daniel Vitt Ph.D.
Industry	Pharmaceuticals: Major

Management People of Immunic

Name	Title
Dr. Duane D. Nash J.D., M.B.A., M.D.	Executive Chairman
Dr. Daniel Vitt Ph.D.	CEO & Director
Mr. Glenn Whaley CPA	Chief Financial Officer
Dr. Andreas Muehler M.D., Ph.D.	Chief Medical Officer
Mr. Jason Tardio M.B.A.	COO & President
Dr. Hella Kohlhof	Chief Scientific Officer
Ms. Jessica Breu	Head of Investor Relations & Communications
Mr. Inderpal Singh	General Counsel
Mr. Patrick Walsh	Chief Business Officer
Mr. Werner Gladdines	Chief Development Officer

Important FAQs about investing in IMUX Stock from India :

What is Immunic share price today?

Immunic share price today stands at $1.17, Open: $1.17 ; Previous Close: $1.17 ; High: $1.20 ; Low: $1.15 ; 52 Week High: $2.11 ; 52 Week Low: $0.92.

The stock opens at $1.17, after a previous close of $1.17. The stock reached a daily high of $1.20 and a low of $1.15, with a 52-week high of $2.11 and a 52-week low of $0.92.

Can Indians buy Immunic shares?

Yes, Indians can invest in the Immunic (IMUX) from India.

With INDmoney, you can buy Immunic at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immunic at zero transaction cost.

How can I buy Immunic shares from India?

It is very easy to buy Immunic from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunic (IMUX) be purchased?

Yes, you can buy fractional shares of Immunic with INDmoney app.

What are the documents required to start investing in Immunic stocks?

To start investing in Immunic, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.